BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 208 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $23,668,286 | -28.4% | 2,837,924 | -1.4% | 0.04% | -32.8% |
| Q4 2022 | $33,044,342 | -1.0% | 2,878,427 | +8.6% | 0.06% | -1.7% |
| Q3 2022 | $33,385,000 | +8.2% | 2,649,616 | -9.2% | 0.06% | +13.5% |
| Q2 2022 | $30,864,000 | -33.2% | 2,917,209 | +2.7% | 0.05% | -14.8% |
| Q1 2022 | $46,201,000 | +17.4% | 2,841,405 | +0.0% | 0.06% | +29.8% |
| Q4 2021 | $39,351,000 | -4.0% | 2,841,230 | -0.4% | 0.05% | -6.0% |
| Q3 2021 | $40,974,000 | -17.6% | 2,851,384 | -9.3% | 0.05% | -15.3% |
| Q2 2021 | $49,699,000 | +61.5% | 3,143,485 | +3.9% | 0.06% | +51.3% |
| Q1 2021 | $30,770,000 | – | 3,025,606 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |